Impact of Mesh Fixation With Tissue Adhesive

June 28, 2023 updated by: Justyna Drewniak Jakubowska, Hospital Universitario de Móstoles

Impact of Mesh Fixation With Tissue Adhesive on Open Inguinal Hernia Repair

Randomized controlled trial on mesh fixation using cyanoacrylate glue compared to standard suture in open inguinal hernia repair.

Study Overview

Detailed Description

Hernioplasty with suture-fixed mesh is the standard technique for the treatment of inguinal hernia, one of the most frequent pathologies in the Surgery Service. Despite its good results in terms of recurrences, it is currently under review due to the incidence of chronic postoperative pain. Up to half of the patients report some type of pain at one year of follow-up, and 15% report moderate-severe pain.

The objective of the study is to analyze whether the use of tissue adhesive (n-hexyl cyanoacrylate 0.5 ml) for mesh fixation in patients undergoing scheduled open inguinal hernioplasty results in a better postoperative evolution, with less chronic pain and less demand for analgesia, compared with a control group of patients who undergo the same surgical intervention with standard suture repair.

Study Type

Interventional

Enrollment (Estimated)

160

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Madrid
      • Móstoles, Madrid, Spain
        • Recruiting
        • Hospital Universitario de Móstoles
        • Contact:
        • Principal Investigator:
          • Justyna Drewniak

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Elective open inguinal hernioplasty in patients over 18 years old

Exclusion Criteria:

  • Patient refusal
  • Laparoscopic surgery
  • Reintervention surgery
  • Urgent surgery
  • Cyanoacrylate allergy
  • Administration of intraoperative local anesthetics
  • Comorbidities that may affect the requirements of analgesics, such as degenerative arthropathies, fibromyalgia, etc.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Tissue adhesive
Group of 80 patients in which mesh fixation is done using cyanoacrylate glue
Mesh fixation with tissue adhesive (n-hexyl cyanoacrylate) in open hernia repair
No Intervention: Standard suture
Group of 80 patients who undergo hernioplasty with standard suture

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative pain assessed by visual numeric scale
Time Frame: 6 months
Values come from 0 to 10, where 0 means no pain and 10 means the worst imaginable pain.
6 months
Postoperative administration of analgesics
Time Frame: 6 months
Record of dose of analgesics needed: nonsteroidal anti-inflamatory drugs, opioid requirements, other analgesics requirements
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hernia recurrence
Time Frame: 6 months
Hernia recurrence rate after mesh fixation with tissue adhesive
6 months
Hematoma
Time Frame: 1 month
Groin hematoma following hernioplasty with n-hexyl cyanoacrylate
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 29, 2023

Primary Completion (Estimated)

November 29, 2023

Study Completion (Estimated)

November 29, 2023

Study Registration Dates

First Submitted

June 12, 2023

First Submitted That Met QC Criteria

June 28, 2023

First Posted (Actual)

July 6, 2023

Study Record Updates

Last Update Posted (Actual)

July 6, 2023

Last Update Submitted That Met QC Criteria

June 28, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All IPD that underlie results in a publication

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Pain

Clinical Trials on Use of n-hexyl cyanoacrylate for mesh fixation

3
Subscribe